Protalix Biotherapeutics to Present at the Oppenheimer 20th Annual Healthcare Conference

CARMIEL, Israel--(BUSINESS WIRE)--Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX), announced today that Dr. David Aviezer, President and CEO, will present at the Oppenheimer 20th Annual Healthcare Conference on Wednesday, November 4, 2009 at 1:35 PM ET. The conference is being held at the Waldorf Astoria Hotel in New York.

MORE ON THIS TOPIC